Key Insights

Highlights

Success Rate

60% trial completion

Published Results

13 trials with published results (27%)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 75/100

Termination Rate

25.0%

12 terminated out of 48 trials

Success Rate

60.0%

-26.5% vs benchmark

Late-Stage Pipeline

2%

1 trials in Phase 3/4

Results Transparency

72%

13 of 18 completed with results

Key Signals

13 with results60% success12 terminated

Data Visualizations

Phase Distribution

44Total
Not Applicable (11)
Early P 1 (1)
P 1 (11)
P 2 (20)
P 3 (1)

Trial Status

Completed18
Terminated12
Recruiting11
Not Yet Recruiting3
Active Not Recruiting2
Withdrawn2

Trial Success Rate

60.0%

Benchmark: 86.5%

Based on 18 completed trials

Clinical Trials (48)

Showing 20 of 20 trials
NCT05972343Recruiting

COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients

NCT07067138Not ApplicableRecruiting

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

NCT07549139Not ApplicableNot Yet Recruiting

Overcoming Racial Disparities in Screening Mammography

NCT05837455Phase 2Recruiting

NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer

NCT07277738Not ApplicableNot Yet Recruiting

Precision Supplemental Imaging in Women With Dense Breasts

NCT07072728Phase 2Recruiting

Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder

NCT04968964Not ApplicableRecruiting

Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing

NCT06867484Not ApplicableRecruiting

Breast Re-irradiation After Second Ipsilateral Lumpectomy

NCT00572481Phase 2Active Not RecruitingPrimary

Axillary Reverse Mapping

NCT05252390Phase 1Terminated

NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors

NCT06749210Phase 2RecruitingPrimary

DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY

NCT01766297Phase 2Recruiting

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

NCT01758445Phase 2Active Not Recruiting

Proton Radiation for Stage II/III Breast Cancer

NCT05716542Not ApplicableCompleted

Prehabilitation to Revolutionize Oncology: Telehealth Exercise for Cognitive Triumphs (The PROTECT Trial)

NCT02807597Phase 1Terminated

Real-time Intraoperative Breast Cancer Visualization for Margin Assessment

NCT02476786Phase 2Recruiting

Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score

NCT06981208Not ApplicableRecruiting

ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and Satisfaction

NCT06711939Not Yet RecruitingPrimary

Vocorder Device Validation in Clinical Settings - Continuous Monitoring of Individuals (Vocorder Clinical Validation-VCV)

NCT06595901Completed

Mental and Cognitive Health and Physical Activity in the Perioperative Breast Cancer Setting

NCT06471673Phase 1Recruiting

A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer

Scroll to load more

Research Network

Activity Timeline